Genomic Health, Inc

Company Details:

Company Symbol: GHDX
Sector: Healthcare & Medical Devices
Company Rating: neutral
URL: http://www.genomichealth.com/

Related Research

  • 05/03/12 Morning Note B. Riley & Co. Morning Notes: AEO, AXTI, CALD, CHRS, GHDX, GLUU, GSM, HOTT, JDSU, KTOS, LOOP, NEWP, PPC, ROVI, UNTD, VCLK, ZUMZ
  • 05/02/12 Desk Report GHDX (Neutral; $28.00): Q1 revenue and EPS in line, excluding non recurring Medicare payments; growth initiatives for new indications and products…
  • 05/01/12 Morning Note B. Riley & Co. Morning Notes: ABTL, ACCL, AXTI, BIRT, DENN, GHDX, GPX, HOTT, IVAC, JDSU, KONA, LLNW, MCHX, NEWP, PACW, PCOM, PRGX, ROVI, SHOO, SNAK,…
  • 02/07/12 Morning Note B. Riley & Co. Morning Notes: ACW, CALD, CSTR, GHDX, GSM, OCLR, OPXT, SABA, STMP, VSAT, VTSS
  • 02/06/12 Update GHDX (Neutral; $28.00 PT) Q4 and FY 2011 revs in line, earnings $0.01 light; newly issued 2012 guidance illustrates reinvestment priorities; Announces…
  • 02/03/12 Morning Note B. Riley & Co. Morning Notes: BEBE, BOFI, BC, CMO, EGHT, GHDX, ITI, OPLK, PII, SIMG, SIMO, VSAT, WTSLA
  • 12/09/11 Morning Note B. Riley & Co. Morning Notes: AKAM, GHDX, LTRE, PPC, VTSS
  • 12/09/11 Update GHDX (Neutral; $28.00): Presence at SABCS Impressive; Near Term Opportunity Already Reflected in Valuation; Downgrading to “Neutral” from a “Buy”…
  • 11/02/11 Morning Note B. Riley & Co. Morning Notes: AGNC, BIRT, DENN, DRCO, GHDX, JDSU, KTOS, MSPD, MYGN, OPXT, SHOO, SIMO, TXRH, UEIC, UNTD, VCLK, YHOO
  • 11/02/11 Update GHDX (Buy; $28.00): Reduction in licensing fees contributes to nice EPS beat; underlying business trends remain in line with expectations. Maintain…
  • 11/01/11 Morning Note B. Riley & Co. Morning Notes: ANH, AOL, BBRG, BJRI, BMTC, CIDM, COHR, CVU, DRCO, Focus List, GHDX, GPX, JDSU, LIOX, MSPD, MYGN, NARA, OPXT, Q3 '11…
  • 10/05/11 Morning Note B. Riley & Co. Morning Notes: ACW, BEBE, CALD, GHDX, MSPD, Molecular Diagnostic Industry, MYGN, NEWP, VRML, WTSLA, ZUMZ
  • 10/04/11 Initiation of Coverage B. Riley & Co. Industry Initiation: A Secular Change in Disease Management Now Ripe for Investment - Initiating Coverage of Molecular Diagnostic Companies:…
  • 10/04/11 Initiation of Coverage GHDX (Buy; $28.00): Compelling valuation creates attractive entry point; initiating coverage with a Buy rating and a $28.00 price target